Clinical Trial Update: Intravitreal Injections of Melphalan for Retinoblastoma [NA]

View source ↗

Summary

A clinical trial investigating intravitreal injections of melphalan for retinoblastoma has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Retinoblastoma

Drugs mentioned

• Melphalan (Melphalan)

Snippet

Sponsor: Hadassah Medical Organization | Conditions: Retinoblastoma | NA | Status: TERMINATED